Capital expenditure · 2019–2025
Universe Pharmaceuticals capital expenditure
$267M+28.1% · FY2025
Universe Pharmaceuticals (UPC) reported $267M in capital expenditure for fiscal 2025, +28.1% year on year.
| Fiscal year | Capital expenditure | Change | Filing |
|---|---|---|---|
| FY20252025-09-30 | $267M | +28.1% | Open → |
| FY20242024-09-30 | $208M | +371.6% | Open → |
| FY20232023-09-30 | $44.2M | +47,037.2% | Open → |
| FY20222022-09-30 | $93,703 | −78.9% | Open → |
| FY20212021-09-30 | $444,505 | +758.2% | Open → |
| FY20202020-09-30 | $51,798 | −40.0% | Open → |
| FY20192019-09-30 | $86,324 | — | Open → |
Capital expenditure — Capital expenditure is the cash the company spent during the year on property, plant and equipment — factories, stores, servers, vehicles. It appears in the investing section of the cash-flow statement as an outflow and is shown here as a positive amount. Operating cash flow minus this figure is free cash flow.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2019–2025 compound annual growth +281.7%
Capital expenditure at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Universe Pharmaceuticals capital expenditure |url=https://companiesranked.com/en/company/universe-pharmaceuticals/capital-expenditure |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Universe Pharmaceuticals capital expenditure. CompaniesRanked. https://companiesranked.com/en/company/universe-pharmaceuticals/capital-expenditureBibTeX
@misc{companiesranked-en-company-universe-pharmaceuticals-capital-expenditure-2026,
author = {{CompaniesRanked}},
title = {{Universe Pharmaceuticals capital expenditure}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/universe-pharmaceuticals/capital-expenditure}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 20-F · 0001213900-26-009000 · January 29, 2026
{{cite web |title=Universe Pharmaceuticals capital expenditure — 20-F (0001213900-26-009000) |url=https://www.sec.gov/Archives/edgar/data/1809616/000121390026009000/ea0273969-20f_universe.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-01-29}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.